• Home
  • AboutUs
    Development Company Honor Enterprise culture
  • News
    Company Dynamics Industry News Project publicity Tender Notice Buying information
  • R&D
    R & D Center R & D Team technology patent
  • Product
    API Products intermediate product
  • Qualification
    Quality Assurance Qualification Certification Production Management
  • HR
    Talent Policy Social Recruitment Campus Recruitment
  • ContactUs
中文  /  EN
  • Home
  • AboutUs
    Development Company Honor Enterprise culture
  • News
    Company Dynamics Industry News Project publicity Tender Notice Buying information
  • R&D
    R & D Center R & D Team technology patent
  • Product
    API Products intermediate product
  • Qualification
    Quality Assurance Qualification Certification Production Management
  • HR
    Talent Policy Social Recruitment Campus Recruitment
  • ContactUs
  • Language: 中文 / EN

DiJia Dynamic

DiJia Dynamic

 

  1. Current Location:
  2. Home Page > DiJia Dynamic
  • Company Dynamics
  • Industry News
  • Project publicity
  • Tender Notice
  • Buying information
  • 2023

    04-28

    Leaders of China Energy Chemical Geological Union and other leaders visited Degas for investigation

    On the morning of April 20, 2023, Jia Haitao, vice chairman of the China Energy Chemical Geological Union, and Wang Jisheng, chairman of the Shandong Petrochemical Union, visited Dijia Pharmaceutical Group Co., Ltd. Zhao Tang'e, member of the Party Group and Vice Chairman of the Weihai City Federation of Trade Unions, Wendeng

  • 2023

    02-15

    Degas Group held a kick-off meeting for on-site assessment and preliminary exchange of chemical process safety management elements.

    Recently, the on-site evaluation and preliminary exchange of chemical process safety management elements of Dijia Pharmaceutical Group Co., Ltd. was successfully held. The company's main leaders and project evaluation leaders were invited to attend the meeting. More than 70 people were in charge of various departments and workshops of Dijia Group.

  • 2022

    12-12

    Diga 3 varieties passed GMP inspection and added 2 new products with marketing qualifications

    A few days ago, an expert group from Shandong Food and Drug Evaluation and Inspection Center visited Dijia Group to conduct on-site GMP inspection (dynamic) of our company's bulk drugs (sildenafil citrate and rivaroxaban) and import of bulk drugs (bupropion hydrochloride)

  • 2022

    12-06

    Dijia Pharmaceutical Group Selected in 2022 Weihai Green Factory

    A few days ago, the list of green manufacturing system construction in Weihai City in 2022 was announced, and Dijia Pharmaceutical Group Co., Ltd. was selected into the list of green factories. Weihai City green manufacturing system construction selection is organized by the Municipal Bureau of industry and information technology to create, and through the expert review meeting,

  • 2022

    11-24

    Dika selected a new generation of information technology and manufacturing integration development pilot demonstration project list

    A few days ago, the list of pilot demonstration projects for the integration and development of the new generation of information technology and manufacturing industry in 2022 was announced. dijia pharmaceutical group co., ltd. was selected into the typical application scenario of industrial internet by virtue of the information management of hazardous enterprises based on the safe production of industrial internet.

  • 2022

    10-31

    Dijia Pharmaceutical Group was selected into the list of the second batch of technological innovation projects in Shandong Province in 2022.

    A few days ago, the Shandong Provincial Department of Industry and Information Technology issued the "Notice on Printing and Distributing the Second Batch of Technological Innovation Project Plans in Shandong Province in 2022". Five projects from 4 companies in Weihai City were selected, and Dijia Pharmaceutical Group was on the list. Shandong Province plans to carry out innovative projects,

  • 2022

    10-27

    Patent Report: Degas Authorized Invention Patents Add 3 New Cumulative Patents Up to 85

    Since September, Dijia Pharmaceutical Group Co., Ltd., a subsidiary of Disha Pharmaceutical Group, has added 3 authorized invention patents. Up to now, Dejia Pharmaceutical has added 15 authorized invention patents this year, with a total of 85 invention patents. DIGA PHARMACEUTICAL GROUP CO., LTD.

  • 2022

    09-29

    The expert group of the provincial safety committee visited Degas to carry out guidance and inspection services.

    On September 18, a group of six experts from the provincial safety committee, led by Huang Wei, a senior engineer of Qingdao University of Science and Technology, and composed of senior engineers from Qingdao University of Science and Technology, Mingquan Investment Holding Group, and Bluestar Petroleum Jinan Branch, came to Dijia Pharmaceutical Group to carry out dangerous

  • 2022

    09-14

    Safety and environmental protection experts from outside the province arrive in Degas for professional diagnostic tests.

    On September 8, the safety expert group, environmental protection expert group and relevant leaders of Weihai Wendeng Economic Development Zone Management Committee of Shenyang Research Institute of chemical industry arrived at Dijia pharmaceutical group to conduct professional diagnosis on Dijia's safety and environmental protection management. Diagnostic examination work

  • 2022

    09-09

    Experts from the Ministry of Ecology and Environment visited Dejia to inspect soil prevention and control work.

    On the afternoon of August 30, Jiang Jing and Shen Zongze, senior engineers of the Soil Center of the State Ministry of Ecology and Environment, Liu Kai of the Soil Center of the Shandong Provincial Department of Ecology and Environment, and relevant leaders of the Weihai Municipal Bureau of Ecology and Environment visited Dejia to check the soil prevention and control work and the soil source prevention and control project. test

  • A total of 691 articles
  • First page
  • Previous Page
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • Next Page

Company Dynamics

 

Learn more

Industry News

 

Learn more

Project publicity

 

Learn more

Tender Notice

 

Learn more

Buying information

Learn more
Terms of Use Privacy Overview Version Description Technical Description

Copyright©Degas Pharmaceutical Group Co., Ltd. All Rights Reserved. Lu ICP Bei No. 2023019171-2Lu Gong Net Anprepared No.